| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.07 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.083 | 0.08 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.08 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.08 |